Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

ICICI Lombard Gen net profit at Rs282 cr, up 24 %,in Q4Fy2020

by AIP Online Bureau | May 2, 2020 | Indian News, Non-Life, Reinsurance

  Mumbai: With improved loss ratio, the net profit of ICICI Lombard General Insurance,the largest private sector general insurer, grew by 23.8 per cent to Rs 282 crore in Q4 FY2020 from Rs 228 crore in Q4 FY2019. The general insurer which has been degrowing its...

Maharashtra to provide free & cashless health insurance cover to its people

by AIP Online Bureau | May 2, 2020 | Disaster & Management, Eco/Invest/Demography, Health, Indian News

  Jalna: Maharashtra Health Minister Rajesh Tope announced that all citizens will be covered under the state government's health scheme, and Maharashtra will be the first state to provide free and cashless insurance protection to its people.   Speaking...

COVID-19 death toll rises to 1,218, cases to 37,336

by AIP Online Bureau | May 2, 2020 | Disaster & Management, Eco/Invest/Demography, Health, Indian News

New Delhi: The death toll due to COVID-19 rose to 1,218 and the number of cases climbed to 37,336 in the country on Saturday, according to the Union Health Ministry.   The number of active COVID-19 cases stood at 26,167, while 9,950 people have recovered and one...

U.S. emergency approval broadens use of Gilead’s COVID-19 drug remdesivir

by AIP Online Bureau | May 1, 2020 | Disaster & Management, Eco/Invest/Demography, Facts, Health

WASHINGTON: Gilead Science Inc’s antiviral drug remdesivir was granted emergency use authorization by the U.S. Food and Drug Administration for COVID-19 on Friday, clearing the way for broader use of the drug in more hospitals around the United States.  ...

Maker of coronavirus trial drug aims for wide distribution – Gilead CEO

by AIP Online Bureau | May 1, 2020 | Disaster & Management, Eco/Invest/Demography, Facts, Health

  Gilead Sciences, which manufactures remdesivir, is focused on making the experimental coronavirus drug accessible and affordable to as many people as possible once it is approved, Chief Executive Officer Daniel O’Day said on Friday.   Interest in...
« Older Entries
Next Entries »

Recent Posts

  • Aon hires 2 professionals to build up its data center expertise
  • LIC,New India and GIC Re remain as Domestic Systemically Important Insurers in FY26:IRDAI
  • Insurers have to submit compliance reports on checking “dark patters” in 15 days:IRDAI
  • New India names new CRO and CUO
  • SC orders SIT to name NIC CMD in FIR for probing criminal lapses in a motor accident fraud claim case

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy